Hosted by King's Innovation Catalyst, this one hour webinar will explore the external innovation funding and academic engagement opportunities available through partnerships with global pharmaceutical company, Servier.
Guest speaker:
Emmanuel NONY, Ph.D., Director R&D External Innovation Europe, Servier Institute of Therapeutic Innovation.
The webinar is intended to be interactive, and will cover the following:
- Overview of Servier’s R&D priority areas
- Servier’s perspectives of the ‘challenges & solutions’ for optimal academic R&D collaboration,
- Outline of the aspects Servier considers when undertaking academic research collaborations and the various models for collaboration,
- Examples (on a non-confidential basis) of successful academic collaborations,
- Audience Q&A
This webinar is open to all within King’s and will be of particular relevance to researchers and associated teams in:
Oncology
- Precision Medicine (clear patient selection strategy in indications of high unmet need)
- Neuro-oncology (glioma / GBM)
- Gastrointestinal tumors e.g., colorectal, pancreatic, gastric cancers
- Haem-onc (The acute leukemias (AML / MDS, ALL)
Modalities
- small molecule targeted therapies, antibodies (mAb, ADC, bi-tri-specific, TCE) and oligonucleotides.
Neurology - Rare disorders with high unmet medical needs such as
- rare movement disorders (e.g., FA, SCA, MSA, PSP, HD)
- neuromuscular disorders (e.g., ALS, SMA, DMD, FSHD, DM, MG)
- refractory epilepsies (e.g., DS, LGS, JS, WS).
